| Execution period | 5 years each |
|---|
BSE filing, NSE: EMUDHRA. Summary written from the filing by ALFA Finder's alert engine.
eMudhra Ltd: key numbers
- Share price
- ₹384.45
- Market cap
- ₹3,184 Cr
- Revenue (annual)
- ₹701.6 Cr
- Net profit (annual)
- ₹107.8 Cr
- P/E (TTM)
- 26.0×Sector 46.5×
- Promoter holding
- 54.40%+0.00% QoQ
- FII holding
- 3.54%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from eMudhra Ltd
All →eMudhra Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs2,070Mn (+19.6% YoY), PAT Rs334Mn (+26.3%), EBITDA margin 24.5%. Enterprise Solutions drives growth; certificate incident to hit H2 revenue.
eMudhra Results Update
eMudhra's Q2 FY27 PAT rose 26.3% to INR 334 Mn on 19.6% higher total income. It will exit its TLS certificate business, about 1% of revenue.
eMudhra Q2 FY27 Results: Net Profit ₹33.5 Cr, Up 26.9% YoY
eMudhra Ltd reported revenue from operations of ₹207 Cr (+19.7% YoY) and net profit of ₹33.5 Cr (+26.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹33.5 Cr · +26.9% YoY
eMudhra Business Update
eMudhra appointed KPMG to conduct an independent review of a previously reported incident. This follows the company's October 21 press release commitment to engage an external reviewer.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
eMudhra Credit Rating
eMudhra Limited's credit rating was revised by ICRA to [ICRA]A (Stable)/[ICRA]A1 on Rs. 35 Crore unallocated limits. The review followed a material event in the global TLS certificate business.
Other management change announcements
All →Jivial Industries Management Change
Jivial Industries appointed Shivam Dineshbhai Sakariya as Additional Non-Executive Independent Director effective 5 November 2026. The NRC recommended the appointment.
Dr. Agarwals Health Care Management Change
Dr Agarwals Health Care reports Mr. Amar Agarwal's redesignation from Chairman and Non-Executive Director to Executive Director, effective 1 November 2026. The change was approved at a board meeting held on 5 November 2026.
Texmaco Rail & Engineering Management Change
Texmaco Rail & Engineering has re-appointed Mr. Udyavar Vittal Kamath as an Executive Director (WTD) with effect from 1 February 2027 for a 12-month term. The filing is a Regulation 30 management change disclosure.
- Execution
- 12 months from 1 February 2027
Windlas Biotech Management Change
Windlass Biotech reports Mr. Ashok Kumar Windlass ceased as Executive Director, resigning for succession planning, effective 5 November 2026. He moves to Founder President, and Hitesh Windlass becomes Managing Director.
Panasonic Energy India Company Management Change
Panasonic Energy India's Company Secretary and Compliance Officer, Srishti Jain, has resigned effective 30 November 2026. The board accepted the resignation at its 5 November 2026 meeting.
Varvee Global Management Change
Varvee Global's statutory auditor, Pankaj R Shah & Associates, resigned with immediate effect on 5 November 2026, citing preoccupancy with other audit assignments. The filing is a mandatory Regulation 30 auditor-resignation disclosure with no monetary value.